tbuckley/cabot-search huggingface dataset:
New England Journal of Medicine, Boston
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Effects of PBB on Cattle. II. Gross Pathology and Histopathology
Authors: P. D. Moorhead, L. B. Willett, F. L. Schanbacher
Journal: Environmental Health Perspectives (1978)

Toxicosis was induced in pregnant Holstein heifers by feeding FireMaster BP-6 (polybrominated biphenyls) in daily oral doses of 25 g/head/day for 33--60 days. The individual heifers were dosed until each became moribund (days 33, 36, 39, 40, 41, or 66), at which time they were necropsied. Gross findings included dehydration, subcutaneous emphysema and hemorrhage, atrophy of the thymus, fetal death with concomitant necrosis of cotyledons, thickened wall of the gallbladder, inspissated bile, edema of abomasal folds, mucoid enteritis, linear hemorrhage and edema of the rectal mucosa, and secondary pneumonia. The livers were enlarged approximately 40%. Kidneys were approximately double the normal size and were pale tan to grey in color. The perirenal lymph nodes were enlarged and edematous. Microscopic changes were the most marked in the kidneys, gallbladder and eyelid. Extreme dilatation of collecting ducts and convoluted tubules with epithelial degenerative changes of cloudy swelling, hydropic degeneration and separation from the basement membrane were principal changes in the kidney. Hyperkeratosis with accumulations of keratin in hair follicles of the epidermis and squamous metaplasia with keratin cysts in the tarsal glands were characteristic findings in sections of eyelids. Moderate to marked hyperplasia and cystic dilatation of the mucous glands in the lamina propria were common changes in the gallbladder. Foci of fatty degeneration and glycogen depletion were observed in liver sections. Necropsy of heifers immediately after 60 days exposure to 0.25 and 250 mg/head/day of PBB showed no gross or histopathological signs indicating toxicosis. Following parturition, at approximately 220 days after the PBB doses, heifers from the 0.25 and 250 mg/head/day groups and their calves were necropsied and displayed no signs of toxicosis.
Cardiovascular Medicine
Journal: JAMA (2002)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Incorrect Wording
Journal: JAMA (1984)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Society proceedings
Journal: JAMA (1934)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Outbreak of Cyclosporiasis—Northern Virginia—Washington, DC—Baltimore, Maryland, Metropolitan Area, 1997
Journal: JAMA (1997)

During July 1997, state and local health departments in Virginia, the District of Columbia (DC), and Maryland received reports of clusters of cases of cyclosporiasis associated with events (e.g., luncheons) held in their jurisdictions during June and July. This report describes the preliminary findings of the investigation of a cluster in Virginia and summarizes the findings from ongoing investigations of the other clusters. Fresh basil has been implicated as the probable vehicle of infection.
Oral aminophylline therapy. Increased dosage requirements in children
Authors: D. E. Zaske
Journal: JAMA (1977)

While monitoring oral aminophylline (theophylline ethylenediamine) therapy, larger doses (milligrams per kilogram) were necessary for children than for adults to achieve similar therapeutic serum levels. The mean apparent theophylline clearance (ATC) determined in 59 children was significantly higher (<i>P</i>&lt;.001) than determined in 114 adults (84.8 versus 51.4 ml/hr/kg). Additionally, the younger children (1 to 9 years) eliminated theophylline more rapidly than the older children (10 to 18 years) (93.8 versus 77.3 ml/hr/kg). When initiating continuous oral aminophylline therapy, dosage guidelines, based on the mean ATC calculated for each group, were predicted, and trough theophylline serum levels of 10μg/ml were obtained. The guidelines for aminophylline were 28.0, 23.2, and 15.6 mg/kg/day administered in four divided doses for the younger children, older children, and adults, respectively. Monitoring of serum levels is suggested to further individualize the patient's aminophylline therapy. (<i>JAMA</i>237:1453-1455, 1977)
Lily
Authors: M. Therese Southgate
Journal: JAMA (2004)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Skeletal muscle glycogen content in patients with cirrhosis
Authors: O Selberg
Journal: Hepatology (1994)

We investigated stable cirrhotic patients for muscle glycogen content. Muscle biopsy samples were taken of 14 patients after overnight fasting. Electron microscopy showed normal intracellular distribution of glycogen (n=8). Muscle glycogen concentration was 16.5 ± 7.1 gm/kg wet muscle weight (normal range, 10 to 20 gm/kg). Basal, early postabsorptive, exerciseinduced and insulin-induced respiratory quotients as well as insulin sensitivity (euglycemic clamp technique, 7.2 pmol insulin/kg body weight/min) and glucose tolerance were assessed. The glucose disposal rate was 23.0 ± 10.1 μmol/kg/min (mean ± S.D.), indicating moderate insulin resistance in these patients. We found no association between basal muscle glycogen content and basal or postprandial respiratory quotient, insulin sensitivity, nutritional status or glucose tolerance. However, there was a positive correlation between muscle glycogen content and exercise, as well as insulin-induced respiratory quotient (r=0.651, p<0.03 and r=0.587, p<0.03, respectively). We conclude that postabsorptive muscle glycogen stores, which are effectively maintained in patients with cirrhosis, are one determinant of exercise-induced and insulin-induced whole body fuel metabolism in these patients. (Hepatology 1994;20:135–141.)
Epilepsy
Authors: Thomas R. Browne, Gregory L. Holmes
Journal: New England Journal of Medicine (2001)

Approximately 2 million persons in the United States have epilepsy,1,2 making the prevalence of this disorder similar to that of type 1 diabetes mellitus.3 Each year, 100,000 new cases of epilepsy are diagnosed in the United States.1,4 Both the prevalence and the incidence of epilepsy are dramatically higher among elderly persons than among those who are younger.1 Thus, many primary care physicians care for a substantial number of patients with epilepsy.EvaluationDiagnosis of a Seizure DisorderThe first step in the evaluation of a patient with possible epilepsy is to determine whether the patient does or does . . .
EndNote Plus 2: Enhanced Reference Database and Bibliography Maker
Authors: S. Satya-Murti
Journal: JAMA (1996)

I have called this principle, by which each slight variation, if useful, is preserved, by the term Natural Selection, in order to mark its relation to man's power of selection.... In cases of this kind, if the variation were of a beneficial nature, the original form would soon be supplanted by the modified form.... —Charles Darwin, 1859. Consider the following four ways to cite the same scientific article: We note that such essential information as author, journal, date, and title does not change, but the formats vary widely. Each format is in current use by a scientific journal. We need the genius of Darwin to tell us why so many variations in citation styles have survived. It is generally considered unethical to manipulate a situation or person. Manipu Screen from EndNote Plus. lating a bibliographic style, however, seems an exception, hence the existence of more than 10 bibliographic manager programs.
Single blind comparative study of ranitidine and cimetidine in patients with gastric ulcer. The Belgian Peptic Ulcer Study Group.
Authors: B Stephens, P Barbier
Journal: Gut (1984)

Abstract In a single blind multicentre study, the efficacy and safety of ranitidine was compared with cimetidine in patients with gastric ulcer confirmed by endoscopy. Patients were randomly allocated to receive either 150 mg ranitidine twice daily, or 200 mg cimetidine three times a day and 400 mg at night for four weeks; patients with unhealed ulcers continued the same treatment for a further two weeks. Out of 260 patients, 197 were analysed. Of the ranitidine treated patients, 66% were healed after four weeks and 78% after six weeks and of the cimetidine treated patients 62% were healed after four weeks and 87% after six weeks. These differences are not significant. These results confirmed that ranitidine is as effective as cimetidine in the acute treatment of gastric ulcer.
通过形态特征以及人乳头瘤病毒基因型预测治疗皮肤疣的疗效
Authors: G.K. Hogendoorn, S.C. Bruggink, M.N.C. de Koning, J.A.H. Eekhof, K.E. Hermans, R. Rissmann, J. Burggraaf, R. Wolterbeek, K.D. Quint, S.T.P. Kouwenhoven, J.N. Bouwes Bavinck
Journal: British Journal of Dermatology (2018)

皮肤疣是由“人乳头状瘤病毒”(HPV) 引起的,在儿童和成年人中的发病率都很高。只有大约一半的皮肤疣可在治疗后消失。该研究旨在预测皮肤疣中的人乳头瘤病毒类型,更重要的是,预测哪类皮肤疣可能在治疗后消失。鉴于此,该研究涉及了患者特征以及皮肤疣特征。该研究使用了新的皮肤疣标准诊断工具(CWARTS 诊断工具)对皮肤疣外观打分,并且对 23 种不同的病毒类型进行了试验。所用治疗包括一氯乙酸、冷冻疗法或联合使用冷冻疗法和水杨酸。研究共涉及 159 名患者的 311 处皮肤疣。皮肤疣中的黑点表明存在人乳头状瘤病毒。如果皮肤疣中含人乳头状瘤病毒 2 型、27 型或 57 型,则大多数治疗方法的疗效较差。但这不适用于手部或身体部位的皮肤疣,前提是使用冷冻疗法治疗。表现胼胝或者位于皮肤深层的皮肤疣采用冷冻疗法的疗效较差。总之,皮肤疣外观以及所含人乳头状瘤病毒的类型会影响治愈机会。因此,今后医护人员在选择寻常疣及跖疣治疗方案时应考虑这一点。
Clapd (Clarithromycin, Pomalidomide, Dexamethasone) Therapy In Relapsed Or Refractory Multiple Myeloma
Authors: Tomer M Mark, Angelique Boyer, Adriana C Rossi, Dennis Kwon, Roger N Pearse, Faiza Zafar, Karen Pekle, Linda Tegnestam, David Jayabalan, Scott A Ely, Morton Coleman, Selina Chen-Kiang, Ruben Niesvizky
Journal: Blood (2013)
<i>QuickStats</i>: Percentage* of Adults Aged ≥18 Years Who Currently Use E-Cigarettes,† by Sex and Age Group — National Health Interview Survey,§ 2016
Journal: MMWR Morbidity and Mortality Weekly Report (2018)

49 50-64 ≥65 Percentage Age group (yrs) Men Women * With 95% confidence intervals indicated with error bars.† Based on a positive response to the question "Have you ever used an e-cigarette even one time?"and a response of "every day" or "some days" to the follow-up question "Do you now use e-cigarettes every day, some days, or not at all?"The denominator was adults aged ≥18 years.§ Estimates are based on household interviews of a sample of the civilian, noninstitutionalized U.S. population and are derived from the National Health Interview Survey Sample Adult component.In 2016, 3.8% of men and 2.6% of women aged ≥18 years currently used e-cigarettes.Among men, current e-cigarette use decreased with advancing age, from 7.1% among men aged 18-24 years to 4.8% among men aged 25-49 years, 2.6% among men 50-64 years, and 1.1% among men aged ≥65 years.Among women, current e-cigarette use increased between ages 18-24 years (2.3%) and 25-49 years (3.3%) and decreased between ages 50-64 years (3.0%) and ≥65 years (0.9%).A greater percentage of men aged 18-24 years and 25-49 years currently used e-cigarettes compared with women in the same age groups.
NEW BOOKS
Journal: JAMA (1969)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Cases in the Hospital Practice of T. M. Greenhow, Esq., Senior Surgeon to the Newcastle-on-Tyne Infirmary
Authors: C. J. Gibb
Journal: BMJ (1846)

NEWCASTLE-ON-TYNE INFIRMARY.39 not to despair of producing the desired effect, however tedious the imiproveinent may be, for even where cures canniot be effected, very satisfactory relief may be given.As regards the other case, that of W. F., I liave to give an equally good account.He has continued to progress nost favourably, having paissed the summnr in an exceedingly improved state of healtlh, and ha been able to take excursions to Richnmond,
Pneumothorax complicating pulmonary emphysema
Authors: R. B. George
Journal: JAMA (1975)

Clinical and roentgenographic findings were compared in patients 40 years of age and over and in those under 40 who were treated for acute unilateral pneumothorax. Dyspnea and anxiety were prominent in the older individuals, although pneumothoraces were usually small. Because physical findings were often unreliable, roentgenograms were required. In the presence of pulmonary emphysema, loss of retractility prevented total collapse of the underlying lung. Increased intrapleural pressure caused overexpansion of the chest wall and depression of the diaphragm without much mediastinal shifting. Partial collapse of emphysematous lobes demonstrated bullae that were not previously obvious. Respiratory failure developed in five patients over 40 years of age, but four of them recovered after relief of the pneumothorax. Mortality for the group was low and related to associated pulmonary diseases. (<i>JAMA</i>234:389-393, 1975)
Annals of Allergy, St. Paul
Journal: JAMA (1969)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
Authors: Mary J. Choi, Caitlin M. Cossaboom, Amy N. Whitesell, Jonathan W. Dyal, Allison Joyce, Rebecca L. Morgan, Doug Campos-Outcalt, Marissa Person, Elizabeth Ervin, Yon C. Yu, Pierre E. Rollin, Brian H. Harcourt, Robert L. Atmar, Beth P. Bell, Rita Helfand, Inger K. Damon, Sharon E. Frey
Journal: MMWR Recommendations and Reports (2021)

This report summarizes the recommendations of the Advisory Committee on Immunization Practices (ACIP) for use of the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the United States.The vaccine contains rice-derived recombinant human serum albumin and live attenuated recombinant vesicular stomatitis virus (VSV) in which the gene encoding the glycoprotein of VSV was replaced with the gene encoding the glycoprotein of Ebola virus species Zaire ebolavirus.Persons with a history of severe allergic reaction (e.g., anaphylaxis) to rice protein should not receive Ervebo.This is the first and only vaccine currently licensed by the Food and Drug Administration for the prevention of Ebola virus disease (EVD).These guidelines will be updated based on availability of new data or as new vaccines are licensed to protect against EVD.ACIP recommends preexposure vaccination with Ervebo for adults aged ≥18 years in the U.S. population who are at highest risk for potential occupational exposure to Ebola virus species Zaire ebolavirus because they are responding to an outbreak of EVD, work as health care personnel at federally designated Ebola treatment centers in the United States, or work as laboratorians or other staff at biosafety level 4 facilities in the United States.Recommendations for use of Ervebo in additional populations at risk for exposure and other settings will be considered and discussed by ACIP in the future.
Brine
Journal: JAMA (2004)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal